White Wolf Capital LLC

About The Fund

White Wolf Capital LLC, also known as Kester Capital, is a leading UK private equity investor with a focus on the technology and healthcare sectors. With its headquarters at 24 Grosvenor Street, London, W1K 4QN, United Kingdom, the firm brings together an experienced team with over 100 years of collective investment experience. Kester Capital is specialized in dealing with middle-market enterprises, typically with an enterprise value ranging between £15-100 million and seeking equity investment of over £15 million. Their investment thesis centers around providing first-time institutional capital to UK businesses that exhibit strong growth potential and ambition. The fund's specialties include supporting portfolio companies through expansion, executing management buy-outs/leveraged buy-outs (MBO/LBO), and implementing both organic and acquisitive growth strategies, thereby driving each business forward to achieve their objectives. As a private equity fund, Kester Capital places a high priority on responsible investment, with Environmental, Social, and Governance (ESG) considerations being central to their investment philosophy. The firm has consistently supported its portfolio companies with bolt-on acquisitions, where 75% of portfolio companies are encouraged to grow through additional acquisitions. The firm's portfolio ranges across various sectors including Healthcare, Information & Data, and Technology, with key investments in businesses such as EMAS Pharma, The Boundary, GXP Engaged, MAP Patient Access, and DC Byte among others. Each of these businesses has been carefully selected to benefit from long-term market growth drivers in their respective fields, be it outsourcing of clinical research, R&D in specialist therapeutic areas, or the increasing trend toward digitalization. Kester Capital's team, led by managing partners with a longstanding collaboration since 2002, offers a dynamic combination of strategic support and the deployment of capital to help their investee companies thrive.